The Proteomics Payoff
Now that the human genome project is done, proteins are set to displace genes as the new darlings of drug discovery. But are biologists up to the task?
MIT News: Jan/Feb 2012
TR: Oct 2001 PDF issue
Megahertz, shmegahertz. A few iconoclasts are building computer chips that dispense with the traditional clock. But they face big barriers in bringing their idea into the mainstream.
Now that the human genome project is done, proteins are set to displace genes as the new darlings of drug discovery. But are biologists up to the task?
It takes years and millions to get a new drug to market. New techniques might burrow through the mountain of genome data and break the bottleneck.
The CEO of Human Genome Sciences, Bill Haseltine, has created a powerful new tool that he just knows will revolutionize the discovery of new medicines.
The Defense Department agency that midwifed the Internet has a uniquely effective strategy to spur innovation-and plenty of hot new technologies in its pipeline.
Ethernet inventor Bob Metcalfe and Nobelist Walter Gilbert, now both venture capitalists, meet to pick the most significant emerging technologies in IT and biotech.
From the editor in chief
Digital technologies have created the "open-source" university.
Two mathematicians set out to make programming easy-and transformed computing.
Apple is betting on a mongrel operating system to freshen the Macintosh.
Scientists´ curiosity often turns them into world travelers. But the ease of travel makes it hard to really get away.
Ecotourism, meet teletourism. You´ve seen it on TV. Now see it in person.
The Internet and globalization are creating new battle lines between producers and distributors of content.
Sugars could be biology´s next sweet spot.
How a maglev train works.
Search Technology Review's Magazine articles: